The AtaiBeckley acquisition follows new federal efforts to accelerate research, regulatory review and clinical preparations for psychedelic therapies.

Regulators are sifting through hundreds of comments about how a state should design its standard package.

Regulators have posted a code list that plans and providers can use to frame disputes.

Seven in 10 health care professionals said the system is less stable today than it was two years ago.